ASTION PHARMA A/S: Financial statements 2014
CVR: 34224781
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
ASTION PHARMA A/S (CVR 34224781) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -1,242,163 and a net result of DKK -3,436,228 compared with DKK -1,508,697 the year before. Equity in the 2014 report amounted to DKK 21,319,708. The solvency ratio was 49%.
- Gross Profit
- DKK -1,242,163
- Profit/Loss
- DKK -3,436,228
- Equity
- DKK 21,319,708
- Total Assets
- DKK 43,546,310
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -1.2 mio. | -3.4 mio. | 21.3 mio. | - |
| 2013 | - | -804 t. | -1.5 mio. | 24.8 mio. | - |
| 2012 | - | -1.1 mio. | -1.9 mio. | 26.3 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
ASTION PHARMA A/S has published its annual report for 2013. Gross profit came to DKK -804,182, and the net result was DKK -1,508,697.
As of May 1, 2014, Morten Just Petersen is registered as director of ASTION PHARMA A/S.
As of May 1, 2014, Morten Weidner has stepped down as director of ASTION PHARMA A/S.
About ASTION PHARMA A/S
ASTION PHARMA A/S is a Danish company of the type Aktieselskab based in Vissenbjerg, founded in 2012. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named AP NEWCO A/S. The management consists of Torben Rønje. The board consists of Ib Henrik Rønje (chair), Henrik Grønfeldt-Sørensen and Torben Rønje. The company is owned by KAPITALFORMIDLINGS INSTITUTTET A/S. The company has 0 employees (2017). In 2025, the company reported a gross profit of DKK -18,071 and a net result of DKK -164,736 compared with DKK -246,248 the year before. Equity in the 2025 report amounted to DKK -5,950,429.